Molecular docking and molecular dynamics simulations revealed that quercetin binds tightly to the core targets (THBS1, SERPINE1, and IGF1R) of nicotine‐related oral carcinoma, suggesting its potential as a therapeutic agent for oral cancer. Here, IGF1R is linked to lip and oral cavity carcinoma.